Osteobridging protein (OPN) is another highly promising serologic biomarker for the diagnosis of HCC; we have found that it demonstrates diagnostic advantages in small HCC and cases of AFP-negative HCC [28]. This evidence concerns the gene AFP and hepatocellular carcinoma.